Jeri Matera

Medicine · Health Sciences

10h-index10.3kcitations22works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(18), Cancer Genomics and Diagnostics(13), Cancer Diagnosis and Treatment(4), Metastasis and carcinoma case studies(4), 3D Printing in Biomedical Research(3)

Publications22 total

Supplementary Data from Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
2023Open Access
Data from Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
2023Open Access
Data from Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
2023· 1 citedOpen Access
Supplementary Data from Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
2023Open Access
Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer
Annals of Oncology·2014· 94 citedOpen Access
Phase III trial of non-pegylated liposomal doxorubicin (M) in combination with trastuzumab (T) and paclitaxel (P) in HER2+ metastatic breast cancer (MBC).
Journal of Clinical Oncology·2013· 5 cited
Abstract P6-14-02: A Phase 3 Randomized, Controlled Trial of Myocet, Trastuzumab and Paclitaxel vs. Trastuzumab and Paclitaxel for 1st Line Therapy of HER2+ Metastatic Breast Cancer
Cancer Research·2010
Spinal reirradiation using the Cyberknife-preliminary efficacy from a single institution
Journal of Clinical Oncology·2008
Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer
Clinical Cancer Research·2006· 787 cited
Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival
Clinical Cancer Research·2006· 1.0k cited
Circulating endothelial cells (CEC) and circulating tumor cells (CTC) in patients (pts) with metastatic colorectal cancer (mCRC)
Journal of Clinical Oncology·2006· 3 cited
Monitoring circulating tumor cells (CTC) in non-measurable metastatic breast cancer (MBC)
Journal of Clinical Oncology·2005· 13 cited
Presence of circulating tumor cells (CTC) in metastatic breast cancer (MBC) predicts rapid progression and poor prognosis
Journal of Clinical Oncology·2005· 13 cited
Circulating tumor cells - not serum tumor markers - predict survival in metastatic breast cancer
Journal of Clinical Oncology·2005· 6 cited
Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer
Journal of Clinical Oncology·2005· 1.1k citedOpen Access
Cristofanilli M, Hayes DF, Budd GT et al.Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 23:1420-30
2005· 4 cited
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
Clinical Cancer Research·2004· 2.5k cited
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
New England Journal of Medicine·2004· 4.5k citedOpen Access
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with non-malignant diseases
Journal of Clinical Oncology·2004· 164 cited
Monitoring circulating tumor cell (CTC) levels to predict rapid progression in metastatic breast cancer (MBC): A prospective, multi-institutional tria
Journal of Clinical Oncology·2004· 2 cited
page 1 of 2Next →

Frequent Co-authors

Michael Craig Miller(16), W. Jeffrey Allard(16), Leon W.M.M. Terstappen(16), Gerald V. Doyle(11), Daniel F. Hayes(10), Massimo Cristofanilli(9), Madeline Repollet(8), G. Thomas Budd(7), Mark C. Connelly(7), Matthew J. Ellis(6), A. Stopeck(6), Alison Stopeck(5), Chinthalapally V. Rao(5), Arjan G.J. Tibbe(5), Jonathan W. Uhr(5), James M. Reuben(3), Mathew J. Ellis(3), José Baselga(3), Alexey Manikhas(3), Semiglazov Vf(3)